Groowe Groowe / Newsroom / CRL
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CRL News

Charles River Laboratories International, Inc.

High-Throughput Screening Market Report 2026-2034: Technology, Products, Applications, End Users, and Regions | AI, 3D Cell Models, and CRISPR Propel Growth to USD 52.7 Billion

globenewswire.com
AMGN BDX BIO CRL CTAS DHR DLTR LMT TMO

Global Early Toxicity Testing Market Size, Share, and Forecast 2026-2034 | AI and Non-Animal Methods Drive 6.57% CAGR, Creating a USD 2.6 Billion Opportunity

globenewswire.com
BIO BRKR CRL DHR EVTC MRK TMO

High-throughput Screening Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | AI Automation and Asia-Pacific Growth Drive a USD 45.07 Billion Opportunity

globenewswire.com
TMO DHR AGNC MRK GEHC BIO CRL

Global Hybrid CRO Models and Tech-Enabled CRO Market Size, Share, Trends, and Forecasts, 2026-2031 | AI and Rare-Disease Trials Create a USD 28.56 Billion Opportunity

globenewswire.com
CRL ICLR IQV TMO

Healthcare Contract Research Organization (CRO) Market Size and Forecast, 2026-2033 | AI-Enabled Trials and R&D Outsourcing Drive Growth to USD 105.73 Billion at 7.5% CAGR

globenewswire.com
CRL IQV LH TMO

Cell and Gene Therapy Biomanufacturing Market - Size, Share, and Forecast, 2026-2031 | Automation, Viral Vectors, and CDMO Expansion Drive 11.7% CAGR to $8.7 Billion

globenewswire.com
TMO DHR CRL

Global Drug Discovery Market (2026-2031) - AI-Driven Target Identification Accelerates Growth

globenewswire.com
NVDA LLY CHAI TMO ABBV AMGN AZN BDX BMY CRL JNJ MRK NVS PFE REGN SNY VRTX

North America Clinical Trials Market Report 2026-2034: Size, Share, Trends, and Forecast by Phase, Indication, Study Design, Country, and Company | AI Adoption Fuels 6% CAGR

globenewswire.com
CRL IQV ICLR ABCL PFE

NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs

globenewswire.com
ELAB CRL

Global Residual DNA Testing Market Size, Share, Trends, and Forecast, 2026-2033 | Biologics and Gene Therapy Growth Fuels 6.8% CAGR to USD 525.3 Million

globenewswire.com
TMO MRK CRL BIO QGEN MRVI